(verbatim from application) The overall goals of the proposal (IRPG#3) are to explore the molecular mechanisms of hormonal regulation of ROMK channels and to define the role of ROMK channels in forming apical K + channels in the thick ascending limb (TAL). ROMK channels share the key biophysical properties with the native small-conductance ATP-sensitive K+ channel (SKatp) in the TAL and collecting duct. However, mechanisms by which SKstp is regulated in the TAL are not completely understood since the density of the SKatp is low. This difficulty can now be overcome since preliminary results have demonstrated that in the mouse TAL the density of the apical K channels is significantly increased by either adding forskolin or removal of extracellular Ca2+. Thus, the first goal of Specific Aim 1 is to study the biophysical properties of the apical K+ channels in the mouse TAL. The information will be important for further studying the role of ROMK channels in forming the apical K+ channels when the ROMK‑knockout mice are available. The second goal is to explore the hypothesis that interaction between the vasopressin receptor and the Ca2+-sensing receptor (CaR)-mediated action plays a key role in determining the activity of the apical K+ channels in the mouse TAL. The goal of Specific Aim 2 is to examine the role of kinase anchoring proteins in mediating the effect of PKA and PKC in modulating ROMK channel function and phosphorylation. The goal of Specific Aim 3 is to investigate the mechanism by which PGE2 regulates the apical K+ channels in the TAL. The effect of PGE2 has relevance to Bartter's Syndrome where hyperprostaglandinemia is prominent and inhibition of prostaglandin production reverses partially the physiological consequences of impaired TAL function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK054983-03
Application #
6635131
Study Section
Special Emphasis Panel (ZRG1-GRM (02))
Program Officer
Ketchum, Christian J
Project Start
2001-03-01
Project End
2005-01-31
Budget Start
2003-03-01
Budget End
2004-01-31
Support Year
3
Fiscal Year
2003
Total Cost
$246,488
Indirect Cost
Name
New York Medical College
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041907486
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Zhang, Dan-Dan; Gao, Zhong-Xiuzi; Vio, Carlos P et al. (2018) Bradykinin Stimulates Renal Na+ and K+ Excretion by Inhibiting the K+ Channel (Kir4.1) in the Distal Convoluted Tubule. Hypertension 72:361-369
Terker, Andrew S; CastaƱeda-Bueno, Maria; Ferdaus, Mohammed Z et al. (2018) With no lysine kinase 4 modulates sodium potassium 2 chloride cotransporter activity in vivo. Am J Physiol Renal Physiol 315:F781-F790
Wu, Peng; Gao, Zhong-Xiuzi; Duan, Xin-Peng et al. (2018) AT2R (Angiotensin II Type 2 Receptor)-Mediated Regulation of NCC (Na-Cl Cotransporter) and Renal K Excretion Depends on the K Channel, Kir4.1. Hypertension 71:622-630
Ellison, David H (2017) Treatment of Disorders of Sodium Balance in Chronic Kidney Disease. Adv Chronic Kidney Dis 24:332-341
Cuevas, Catherina A; Su, Xiao-Tong; Wang, Ming-Xiao et al. (2017) Potassium Sensing by Renal Distal Tubules Requires Kir4.1. J Am Soc Nephrol 28:1814-1825
Zhang, Chengbiao; Wang, Lijun; Su, Xiao-Tong et al. (2017) ENaC and ROMK activity are inhibited in the DCT2/CNT of TgWnk4PHAII mice. Am J Physiol Renal Physiol 312:F682-F688
Wang, Lijun; Zhang, Chengbiao; Su, Xiao-Tong et al. (2017) PGF2?regulates the basolateral K channels in the distal convoluted tubule. Am J Physiol Renal Physiol 313:F254-F261
Scholl, Ute I; Abriola, Laura; Zhang, Chengbiao et al. (2017) Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma. J Clin Invest 127:2739-2750
Pandey, Varunkumar; Garcia, Victor; Gilani, Ankit et al. (2017) The Blood Pressure-Lowering Effect of 20-HETE Blockade in Cyp4a14(-/-) Mice Is Associated with Natriuresis. J Pharmacol Exp Ther 363:412-418
Ellison, David H; Felker, G Michael (2017) Diuretic Treatment in Heart Failure. N Engl J Med 377:1964-1975

Showing the most recent 10 out of 74 publications